|
|
Article: PPD Reports Third Quarter 2009 Financial Results; Updates 2009 Financial Guidance.(Company overview)(Financial report)
- Article from:
- Biotech Week
- Article date:
- November 11, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
PPD, Inc. (Nasdaq: PPDI) reported its financial and operating results for the third quarter ended September 30, 2009 (see also PPD, Inc.).
PPD recorded net revenue of $341.1 million for the third quarter of 2009, compared to $394.1 million for the third quarter of 2008. Third quarter 2009 income from operations was $46.9 million, compared to $69.9 million for the same period in 2008. Third quarter 2009 diluted earnings per share were $0.32, compared to $0.43 for the same period last year. Segment Performance Development segment net revenue for the third quarter of 2009 was $315.8 million, compared to $358.7 million for the third quarter of 2008. Development ...
Related newspaper, magazine, and journal articles:
|
|
Article: PPD Completes Acquisition of Excel PharmaStudies.
Business Wire;
November 6, 2009 ;
700+ words
...Providing Solid Foundation for PPD's Continued Growth in China and Asia Pacific WILMINGTON, N.C. -- PPD, Inc. (Nasdaq: PPDI) today announced ... organizations in China. The acquisition strengthens PPD's full range of drug development services ...
|
|